Key takeaways:
Some medications can weaken your bones, which can lead to them breaking more easily. This includes some common medications, such as corticosteroids, selective serotonin reuptake inhibitors (SSRIs), and proton pump inhibitors (PPIs).
Other causes of bone loss include certain diabetes medications, loop diuretics, and some seizure medications. Your risk depends on many factors, including the medication, dose, and how long you’re taking it.
If you’re taking a medication that can raise your risk of bone loss, talk to your healthcare provider about ways to keep your bones healthy.
Save on related medications
As we age, the strength and density of our bones weaken. This may lead to low bone density and ultimately raise your risk for bone fractures. Having slightly weaker-than-normal bones is called osteopenia. And very low bone mass is known as osteoporosis. Not everyone with low bone density will develop osteoporosis, but it’s still a key risk factor for future fractures.
Several medications can lower bone density and weaken your bones. If you take one of these, your healthcare provider may keep a closer eye on your bone density with a DEXA (dual-energy X-ray absorptiometry) scan.
Let’s take a closer look at 10 medications that may weaken your bones and raise your risk for fractures.
Search and compare options
1. Corticosteroids
Corticosteroids are prescribed for multiple conditions, including asthma and autoimmune disorders. Some examples include:
Methylprednisolone (Medrol)
Fluticasone (Flovent)
Bone loss is a well-known side effect of taking corticosteroids. That’s because these medications decrease bone formation. Without new bone cells to keep them strong, your bones weaken and become more likely to break.
Bone loss is more likely with high doses of oral steroids. It’s also more likely if you take them for a long period of time or if you’re aged 65 years or over. To avoid this side effect, your healthcare provider may have you take these medications for the shortest amount of time possible. If you’re taking them long-term, your provider will likely monitor your bone density to make sure it stays at a healthy level.
2. SSRIs, such as Prozac
Selective serotonin reuptake inhibitors (SSRIs) are a class of medications that treat depression. Some common SSRIs include fluoxetine (Prozac) and escitalopram (Lexapro). Studies have shown that taking SSRIs might weaken your bones.
Your risk might be higher if you take multiple medications affecting serotonin, a chemical involved with mood. Long-term use can also be a risk factor. If you’re taking an SSRI long-term, your healthcare provider may want to monitor your bone density. And if you’ve been diagnosed with osteoporosis, talk to your provider about the risks and benefits before starting an SSRI.
3. Proton Pump Inhibitors, such as Nexium
Proton pump inhibitors (PPIs) are frequently taken for chronic acid reflux. However, with long-term use, they can lead to bone loss and osteoporosis. Researchers suspect that PPIs may stop your body from absorbing calcium. So instead, your body takes calcium from your bones, which weakens them.
The FDA requires prescription PPIs to include a warning about the risk of bone loss if you take them. Unlike other medications, this risk is linked to both short-term (less than 1 year) and long-term use.
However, the warning doesn’t apply to over-the-counter (OTC) PPIs. That’s because you shouldn’t take OTC versions for more than 2 weeks. Which probably isn’t enough time to affect your bone density.
It’s best to take a PPI for the shortest amount of time necessary. Talk to your healthcare provider if you’re taking a PPI long-term and are concerned about the risk of bone loss.
4. Certain diabetes medications, such as Actos and Invokana
Some Type 2 diabetes (T2D) medications have also been associated with a higher risk of broken bones. These include pioglitazone (Actos) and canagliflozin (Invokana).
About twice as many females with T2D who took pioglitazone had fractures compared to placebo in clinical studies. This higher risk wasn’t observed in males.
In 2015, the FDA added a warning about a higher risk of low bone mass and fractures from Invokana. Your risk can go up as early as 12 weeks after starting treatment. More research is needed to understand if all medications in the SGLT2 inhibitor class have this risk. So far, results are mixed.
5. Anti-androgen medications
Anti-androgen medications are mainly taken to treat prostate cancer. Examples include bicalutamide (Casodex), or Xtandi (enzalutamide).
These medications lower male hormone levels and help prevent prostate cancer from returning. However, they can result in bone loss and osteoporosis. This is because hormones like testosterone play a large role in bone health.
If you take an anti-androgen medication, your healthcare provider will likely monitor your bone density. They may also prescribe a medication like zoledronic acid (Reclast) or denosumab (Prolia). These medications can help prevent bone loss caused by anti-androgen medications.
6. Certain seizure medications
Carbamazepine (Tegretol), phenytoin (Dilantin), and divalproex (Depakote) are taken to prevent seizures. However, they can also cause bone loss.
Vitamin D is a nutrient we need to keep our bones strong — but it’s not active in our bodies right away. First, it has to be converted to 25-hydroxyvitamin D, and then to calcitriol (the active form of vitamin D). But carbamazepine and phenytoin can intervene in this process, as they turn on a liver enzyme that breaks down 25-hydroxyvitamin D before it can be activated, leading to weaker bones.
Valproate, another seizure medication, lowers bone density too, but in a different way. It’s thought to activate cells that break bone down. This leads to bone loss.
You often need to take seizure medications for a long time. So your healthcare provider will likely check your bone health and adjust your medications as needed if low bone density becomes an issue. Your provider may also recommend taking vitamin D and/or calcium supplements.
7. Loop diuretics
Loop diuretics (water pills), like furosemide (Lasix) and bumetanide (Bumex), can lower the amount of calcium in your bones. Some studies show that these medications lower bone density in males and postmenopausal females. They may also raise the risk of fractures, according to some (but not all) studies.
If you take a water pill, ask your healthcare provider if it may affect your bones. They can suggest ways to keep your bones healthy and prevent fractures.
8. Anti-estrogen medications
Anti-estrogen therapies treat or prevent certain types of breast cancer. They block estrogen, which some breast cancers need to grow. Common examples include:
Tamoxifen (Soltamox)
Letrozole (Femara)
Anastrozole (Arimidex)
Exemestane (Aromasin)
These medications can be detrimental to bone health. This is because estrogen plays an important role in preventing bone loss. Blocking estrogen causes your body to break down more bone than it should.
If you take one of these medications, your healthcare provider may prescribe a medication to help prevent bone loss, such as Prolia.
9. Tramadol
Tramadol (Conzip, Qdolo) is an opioid pain medication. It has many risks, and bone fractures might be one of them. One study compared people age 50 and older taking tramadol versus other medications. After 1 year, about twice as many people had hip fractures if they took tramadol versus celecoxib (Celebrex).
Your risk might be higher if you take tramadol for a long time. But more research is needed. Researchers think the risk of broken bones might be due to tramadol raising your risk for falls, rather than any effect it might have on your bones directly.
10. Certain transplant medications, such as cyclosporine
If you’ve received an organ or bone marrow transplant, you’re probably taking medications to suppress your immune system. This helps your body accept the new organ or tissue. But certain organ transplant medications can lead to osteoporosis. Some examples include cyclosporine (Sandimmune, Neoral) and tacrolimus (Prograf, Astagraf XL, Envarsus XR).
While not entirely clear, researchers think these medications might affect the cells that break down and build new bone.
Your healthcare provider will likely monitor your bone density if you’re taking these medications. They may recommend vitamin D and calcium supplements, as well.
What works to keep your bones strong if you’re taking these medications?
Proper nutrition, limiting alcohol, and regular exercise are all ways to prevent osteoporosis and keep your bones healthy.
If you’re taking a medication that makes osteoporosis more likely, your healthcare provider may also recommend one of the following treatment options:
Vitamin D and/or calcium supplements. These vitamins are the building blocks of healthy bones.
Bisphosphonates, such as alendronate (Fosamax) or Reclast. These medications attach to the bone and block the cells that break it down.
Monoclonal antibodies, such as Prolia or romosozumab (Evenity). These medications block proteins that break down bone and help the body make new bone.
Parathyroid hormone analogues, such as teriparatide (Forteo). These medications help stimulate bone growth.
If you have low bone density, the best way to avoid a fracture is to prevent falls. This can be done through strengthening and balance exercises. You can also clear clutter and trip hazards at home.
The bottom line
Common medications, such as corticosteroids, SSRIs, and PPIs, may cause bone loss. Other causes include certain diabetes medications, loop diuretics, and some seizure medications. Bone loss can raise your risk of fractures and may lead to osteoporosis. If you need to take one of these medications long-term, work with your healthcare provider closely to monitor your bone health. They can help you find ways to keep your bones healthy and prevent fractures.
Why trust our experts?



References
Bienz, M., et. al. (2015). Androgen-deprivation therapy and bone loss in prostate cancer patients: A clinical review. BoneKEy Reports.
Briot, K., et al. (2015). Glucocorticoid-induced osteoporosis. RMD Open.
Carbone, L. D., et al. (2009). Loop diuretic use and fracture in postmenopausal women: Findings from the women’s health initiative. JAMA Internal Medicine.
Cauley, J. (2015). Estrogen and bone health in men and women. Steroids.
Cunningham, J. (2007). Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression. Journal of the American Society of Nephrology.
DailyMed. (2022). Actos.
Epstein, S., et al. (1995). Organ transplantation and osteoporosis. Current Opinion in Rheumatology.
Fan, D., et. al. (2019). Effects of valproic acid on bone mineral density and bone metabolism: A meta-analysis. Seizure.
Hadji, P. (2017). Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. Journal of Bone Oncology.
Heidrich, F., et. al. (1991). Diuretic drug use and the risk for hip fracture. Annals of Internal Medicine.
Hussain, A., et al. (2020). Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases.
Lim, L., et. al. (2008). Loop diuretic use and increased rates of hip bone loss in older men: The Osteoporotic fractures in men study. JAMA Internal Medicine.
Meier, C., et al. (2011). Antiepileptics and bone health. Therapeutic Advances in Musculoskeletal Disease.
Nehra, A., et al. (2018). Proton pump inhibitors: Review of emerging concerns. Mayo Clinic Proceedings.
NIH Osteoporosis and Related Bone Diseases National Resource Center. (2018). Bone mass measurement: What the numbers mean.
Rejnmark, L., et. al. (2009). Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: Results From a randomized controlled study with bumetanide. Journal of Bone and Mineral Research.
Sansone, R. A., et. al. (2012). SSRIs: Bad to the bone? Innovations in Clinical Neuroscience.
Thong, B. K. S., et. al. (2019). Proton pump inhibitors and Fracture Risk: A review of current evidence and mechanisms involved. International Journal of Environmental Research and Public Health.
U.S. Food and Drug Administration. (2016). FDA drug safety communication: FDA revises label of diabetes drug canagliflozin (Invokana, Invokamet) to include updates on bone fracture risk and new information on decreased bone mineral density.
U.S. Food and Drug Administration. (2017). FDA drug safety communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors.
Wei, J., et. al. (2020). Association of tramadol use with risk of hip fracture. Journal of Bone and Mineral Research.
Ye, Y., et. al. (2018). Effect of sodium-glucose co-transporter 2 inhibitors on bone metabolism and fracture risk. Frontiers in Pharmacology.












